Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 10 (4) , 845-850
- https://doi.org/10.1016/s0735-1097(87)80279-6
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Effect of the renin-angiotensin system on limb circulation and metabolism during exercise in patients with heart failureJournal of the American College of Cardiology, 1985
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.Circulation, 1983
- Regional and systemic metabolic effects of angiotensin-converting enzyme inhibition during exercise in patients with severe heart failure.Circulation, 1982
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- Angiotensin converting enzyme inhibition in patients with congestive heart failure.Circulation, 1978
- Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.Circulation, 1978
- Local xenon 133 clearance from the quadriceps muscle during exercise in man.Journal of Applied Physiology, 1967
- MEASUREMENT OF BLOOD-FLOW THROUGH SKELETAL MUSCLE BY INTRAMUSCULAR INJECTION OF XENON-133The Lancet, 1964
- Blood-Flow Through Muscle During Rhythmic Contraction Measured BY133XenonScandinavian Journal of Clinical and Laboratory Investigation, 1964